Anika Therapeutics, Inc. Shareholders' Equity
Anika Therapeutics, Inc. (ANIK) had Shareholders' Equity of $137.28 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-29
- 2026-06-30: Stockholders' Equity Attributable to Parent $137.28M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $133.90M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $143.47M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $146.81M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $137.28M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $133.90M 10-Q · filed 2026-07-29 | |
| 2025-12-31 | $143.47M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $146.81M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $147.67M 10-Q · filed 2026-07-29 | |
| 2025-03-31 | $148.40M 10-Q · filed 2026-07-29 | |
| 2024-12-31 | $153.99M 10-Q · filed 2026-07-29 | |
| 2024-09-30 | $179.86M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $210.34M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $208.54M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $212.26M 10-K · filed 2026-03-03 | |
| 2023-09-30 | $270.49M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $274.01M 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $277.59M 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $285.56M 10-K · filed 2026-03-03 | |
| 2022-09-30 | $284.94M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $286.15M 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $285.79M 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $287.08M 10-K · filed 2025-03-17 | |
| 2021-09-30 | $290.06M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $286.80M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $276.66M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $272.40M 10-K · filed 2024-03-15 | |
| 2020-09-30 | $284.45M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $288.44M 10-Q · filed 2021-11-05 | |
| 2020-03-31 | $293.69M 10-Q · filed 2021-11-05 | |
| 2019-12-31 | $288.38M 10-K · filed 2023-03-16 | |
| 2019-09-30 | $281.68M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $250.95M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $269.07M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $263.61M 10-K · filed 2022-03-11 | |
| 2018-09-30 | $255.26M 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $246.60M 10-Q · filed 2019-10-28 | |
| 2018-03-31 | $263.77M 10-Q · filed 2019-10-28 | |
| 2017-12-31 | $263.49M 10-K/A · filed 2021-04-26 | |
| 2017-09-30 | $253.29M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $244.14M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $230.03M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $222.77M 10-K · filed 2020-03-06 | |
| 2016-09-30 | $214.54M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $204.42M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $195.37M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $210.85M 10-K · filed 2019-02-27 | |
| 2015-09-30 | $199.75M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $190.57M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $181.82M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $178.10M 10-K · filed 2018-02-27 | $178.10M 10-K · filed 2015-03-13 |
| 2014-09-30 | $169.70M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $162.39M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $156.57M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $135.63M 10-K · filed 2017-02-24 | $135.63M 10-K · filed 2014-03-13 |
| 2013-09-30 | $128.21M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $119.43M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $112.83M 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $108.92M 10-K · filed 2016-03-10 | $108.93M 10-K · filed 2013-03-14 |
| 2012-09-30 | $103.47M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $100.75M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $98.26M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $94.76M 10-K · filed 2015-03-13 | |
| 2011-09-30 | $92.85M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $91.13M 10-Q/A · filed 2011-08-10 | |
| 2010-12-31 | $85.19M 10-K · filed 2014-03-13 | |
| 2009-12-31 | $82.14M 10-K · filed 2013-03-14 | |
| 2008-12-31 | $60.76M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |